JP2018506533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018506533A5 JP2018506533A5 JP2017541810A JP2017541810A JP2018506533A5 JP 2018506533 A5 JP2018506533 A5 JP 2018506533A5 JP 2017541810 A JP2017541810 A JP 2017541810A JP 2017541810 A JP2017541810 A JP 2017541810A JP 2018506533 A5 JP2018506533 A5 JP 2018506533A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- combination
- adc
- subject
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562115381P | 2015-02-12 | 2015-02-12 | |
| US62/115,381 | 2015-02-12 | ||
| PCT/US2016/017721 WO2016130902A1 (en) | 2015-02-12 | 2016-02-12 | Combination therapy using a cd19-adc and vincristine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018506533A JP2018506533A (ja) | 2018-03-08 |
| JP2018506533A5 true JP2018506533A5 (OSRAM) | 2019-03-22 |
Family
ID=56615120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017541810A Pending JP2018506533A (ja) | 2015-02-12 | 2016-02-12 | Ｃｄ１９−ａｄｃ及びビンクリスチンを使用する組み合わせ療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180028681A1 (OSRAM) |
| EP (1) | EP3256493A4 (OSRAM) |
| JP (1) | JP2018506533A (OSRAM) |
| KR (1) | KR20170117045A (OSRAM) |
| CN (1) | CN107406507A (OSRAM) |
| AU (1) | AU2016219174A1 (OSRAM) |
| CA (1) | CA2972827A1 (OSRAM) |
| EA (1) | EA201791819A1 (OSRAM) |
| HK (1) | HK1247619A1 (OSRAM) |
| IL (1) | IL253287A0 (OSRAM) |
| MX (1) | MX2017009632A (OSRAM) |
| SG (1) | SG11201705476WA (OSRAM) |
| WO (1) | WO2016130902A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230028571A (ko) | 2016-10-28 | 2023-02-28 | 모르포시스 아게 | 항-cd19 항체 및 bcl-2 억제제의 조합 및 이의 용도 |
| CN111683971A (zh) * | 2017-12-23 | 2020-09-18 | 宇越生医科技股份有限公司 | 医药重组受体组成物及方法 |
| CN113195544A (zh) * | 2018-06-07 | 2021-07-30 | 库利南肿瘤股份有限公司 | 多特异性结合蛋白及其使用方法 |
| RU2738802C1 (ru) * | 2019-08-21 | 2020-12-17 | Общество с ограниченной ответственностью "Международный Биотехнологический Центр "Генериум" | Определяющие комплементарность участки для связывания cd3 и содержащая их биспецифическая антигенсвязывающая молекула |
| EP4073122A4 (en) | 2019-12-11 | 2024-03-27 | Cullinan Oncology, Inc. | Anti-cd19 antibodies and multi-specific binding proteins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2382337T3 (es) * | 2004-08-10 | 2012-06-07 | Talon Therapeutics, Inc. | Composiciones y procedimientos para tratar la leucemia |
| CN101218351A (zh) * | 2005-02-15 | 2008-07-09 | 杜克大学 | 抗cd19抗体及其在肿瘤学中的应用 |
| US8444973B2 (en) * | 2005-02-15 | 2013-05-21 | Duke University | Anti-CD19 antibodies and uses in B cell disorders |
| WO2009052431A2 (en) * | 2007-10-19 | 2009-04-23 | Seattle Genetics, Inc. | Cd19 binding agents and uses thereof |
-
2016
- 2016-02-12 AU AU2016219174A patent/AU2016219174A1/en not_active Abandoned
- 2016-02-12 KR KR1020177021477A patent/KR20170117045A/ko not_active Ceased
- 2016-02-12 MX MX2017009632A patent/MX2017009632A/es unknown
- 2016-02-12 WO PCT/US2016/017721 patent/WO2016130902A1/en not_active Ceased
- 2016-02-12 EA EA201791819A patent/EA201791819A1/ru unknown
- 2016-02-12 JP JP2017541810A patent/JP2018506533A/ja active Pending
- 2016-02-12 US US15/550,126 patent/US20180028681A1/en not_active Abandoned
- 2016-02-12 SG SG11201705476WA patent/SG11201705476WA/en unknown
- 2016-02-12 CA CA2972827A patent/CA2972827A1/en not_active Abandoned
- 2016-02-12 CN CN201680010040.1A patent/CN107406507A/zh active Pending
- 2016-02-12 EP EP16749948.2A patent/EP3256493A4/en not_active Withdrawn
- 2016-02-12 HK HK18106901.5A patent/HK1247619A1/zh unknown
-
2017
- 2017-07-03 IL IL253287A patent/IL253287A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015534578A5 (OSRAM) | ||
| JP2017149726A5 (OSRAM) | ||
| JP2015534580A5 (OSRAM) | ||
| JP2016502504A5 (OSRAM) | ||
| JP2011251975A5 (OSRAM) | ||
| JP2015534577A5 (OSRAM) | ||
| JP2012521435A5 (OSRAM) | ||
| JP2016515628A5 (OSRAM) | ||
| NZ588913A (en) | Liver cancer drug | |
| JP2016106150A5 (OSRAM) | ||
| JP2016185995A5 (OSRAM) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2020523356A5 (OSRAM) | ||
| PH12015502628B1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| JP2019530706A5 (OSRAM) | ||
| JP2017512194A5 (OSRAM) | ||
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| JP2018530578A5 (OSRAM) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| JP2011500589A5 (OSRAM) | ||
| CN111867629A (zh) | 抗her2抗体-药物偶联物在治疗癌症中的用途 | |
| JP2021505669A5 (OSRAM) | ||
| MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
| NI202100031A (es) | Formulación basada en ciclodextrina de un inhibidor de bcl-2 |